-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Quince Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- Quince Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$28.2M, a 405% decline year-over-year.
- Quince Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$55.5M, a 71.1% decline year-over-year.
- Quince Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$34.6M, a 33.4% increase from 2022.
- Quince Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$52M, a 42.4% increase from 2021.
- Quince Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$90.3M, a 14.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)